HYCHLORZIDE 25 : Hydrochlorothiazide 25mg Diuretic Support

Aug 27, 2024

Hydrochlorothiazide 25 mg is a thiazide diuretic (water pill) prescribed in India for hypertension, oedema, and congestive heart failure. It works by inhibiting sodium reabsorption in the distal convoluted tubule of the kidney, increasing urine output. Standard adult dose is 12.5–25 mg once daily.

What is Hydrochlorothiazide 25 mg Tablet?

Hydrochlorothiazide (HCTZ) is a benzothiadiazine-class thiazide diuretic in clinical use since 1959. It remains one of the most commonly prescribed antihypertensive agents globally and is listed on the WHO Model List of Essential Medicines. In India, HCTZ 25 mg tablets are used as first-line or adjunct treatment for hypertension, peripheral oedema, and chronic heart failure.

HCTZ belongs to ATC classification C03AA03 — Low-ceiling diuretics, thiazides. It is approved by CDSCO under Schedule H of the Drugs and Cosmetics Act, 1940 — requiring a valid prescription from a registered medical practitioner.

How Does Hydrochlorothiazide Work?

Hydrochlorothiazide acts on the distal convoluted tubule (DCT) of the nephron. It inhibits the sodium-chloride symporter (NCC), preventing reabsorption of Na⁺ and Cl⁻ ions — increasing urinary sodium and water excretion (natriuresis and diuresis).

Mechanism Step	Location	Clinical Result
Inhibits Na⁺/Cl⁻ cotransporter	Distal Convoluted Tubule	Reduced sodium reabsorption
Increased osmotic load in tubule	Collecting duct	Increased urinary water excretion
Reduced plasma volume	Systemic circulation	Decreased cardiac preload
Vasodilation (chronic use)	Peripheral blood vessels	Sustained BP reduction
Increased Ca²⁺ reabsorption	DCT (indirect)	Reduced hypercalciuria risk

The antihypertensive effect in long-term use is partly due to direct arterial vasodilation. BP reduction is evident within 3–4 days, reaching maximum effect at 3–4 weeks.

Indications and Uses

Indication	Therapeutic Category	Evidence Level
Essential Hypertension (mild–moderate)	Cardiovascular	Level A (JNC 8, ACC/AHA)
Oedema — Congestive Heart Failure	Cardiology / Nephrology	Level A
Oedema — Hepatic Cirrhosis	Hepatology	Level B
Oedema — Nephrotic Syndrome	Nephrology	Level B
Nephrolithiasis (calcium oxalate stones)	Urology	Level B
Diabetes Insipidus (nephrogenic)	Endocrinology	Level C
Adjunct in Osteoporosis (reduces urinary Ca²⁺ loss)	Orthopaedics	Level C (off-label)

In the Indian clinical setting, HCTZ is most frequently prescribed in fixed-dose combination (FDC) tablets — commonly with Telmisartan, Losartan, Amlodipine, Metoprolol, or Enalapril.

Dosage and Administration

Patient Group	Indication	Recommended Dose	Frequency
Adults	Hypertension	12.5–25 mg	Once daily (morning)
Adults	Oedema (mild–moderate)	25–50 mg	Once or twice daily
Elderly (>65 years)	Hypertension / Oedema	12.5 mg (start low)	Once daily
Paediatric (6 months–12 years)	As directed	1–2 mg/kg/day	Once or twice daily
Renal Impairment (eGFR <30)	Avoid or caution	Physician discretion	Monitor closely
Hepatic Impairment	Oedema (cirrhosis)	Low dose, titrate slowly	Once daily

Route: Oral tablet, with or without food
Best time: Morning — to avoid nocturia
Duration: As prescribed; do not discontinue abruptly

Side Effects and Adverse Drug Reactions

Side Effect	Frequency	Clinical Significance
Hypokalemia (low potassium)	Common (5–10%)	High — can cause arrhythmias
Hyponatremia (low sodium)	Uncommon (1–5%)	High in elderly
Hyperuricemia (elevated uric acid)	Common	Moderate — may precipitate gout
Postural hypotension / dizziness	Common	Moderate — fall risk in elderly
Hyperglycaemia	Uncommon	Moderate — monitor in diabetics
Photosensitivity	Rare (<1%)	Mild — use sunscreen
Erectile dysfunction	Rare (<1%)	Mild — dose-dependent
Non-melanoma skin cancer (NMSC)	Very Rare	Low at therapeutic doses; monitor long-term

Potassium supplementation or concurrent potassium-sparing diuretics (Spironolactone, Amiloride) are often recommended to prevent hypokalemia — especially in patients on digoxin or antiarrhythmics.

Contraindications and Precautions

Absolute Contraindications:

Anuria or severe renal failure (eGFR < 10 mL/min/1.73 m²)
Known hypersensitivity to hydrochlorothiazide or sulfonamide-derived drugs
Uncorrected severe hyponatremia or hypokalemia

Precautions:

Monitor serum electrolytes (Na⁺, K⁺, Cl⁻) and renal function every 3–6 months
Use with caution in diabetics — HCTZ may impair glucose tolerance
Gout history: monitor serum uric acid
Pregnancy: Category B; avoid in third trimester (neonatal jaundice, thrombocytopenia risk)
Breastfeeding: Passes into breast milk in small amounts; consult physician

Drug-Drug Interactions

Interacting Drug / Class	Effect	Management
ACE Inhibitors / ARBs (Telmisartan, Losartan)	Additive antihypertensive effect	Beneficial combination; monitor BP
NSAIDs (Ibuprofen, Diclofenac)	Reduced diuretic/antihypertensive efficacy	Avoid concurrent use if possible
Digoxin	Hypokalemia increases digoxin toxicity risk	Monitor potassium levels closely
Lithium	HCTZ increases lithium reabsorption → toxicity	Avoid or reduce lithium dose
Corticosteroids (Prednisolone)	Enhanced potassium loss	Monitor electrolytes; supplement K⁺
Antidiabetics (Insulin, Metformin)	HCTZ may raise blood glucose	Monitor blood sugar; adjust dose
Amiodarone	Risk of QT prolongation with hypokalemia	ECG monitoring required

Pharmacokinetic Profile

Parameter	Value	Clinical Relevance
Bioavailability	60–80% (oral)	Good absorption; food has minimal effect
Onset of Action	2 hours	Diuresis begins within 2 hours
Peak Effect	4–6 hours	Maximum BP reduction at 4–6 hours
Duration of Action	6–12 hours	Once-daily dosing sufficient
Protein Binding	~40%	Moderate plasma protein binding
Metabolism	Not hepatically metabolised	Excreted unchanged in urine
Elimination Half-Life	6–15 hours	Prolonged in elderly and renal impairment
Route of Excretion	Renal (95% unchanged)	Dose reduction in renal insufficiency

Key Statistics & Clinical References

Metric / Fact	Value	Source / Year
Global Hypertension Prevalence	1.28 billion adults worldwide	WHO Global Health Observatory, 2023
India Hypertension Prevalence	~28.5% of adults	ICMR-INDIAB Study, 2023
BP Reduction (HCTZ 12.5–25 mg)	-5 to -10 mmHg systolic	Cochrane Review, Musini et al., 2014
Stroke risk reduction with diuretics	~38% relative risk reduction	ALLHAT Trial, JAMA, 2002
Hypokalemia incidence at 25 mg	~8–10% of patients	Sica DA, J Clin Hypertens, 2011
WHO Essential Medicine status	Listed on EML since 1977	WHO Model List, 23rd Edition, 2023
CDSCO Schedule classification	Schedule H (Rx only)	Drugs & Cosmetics Act, India, 1940

Frequently Asked Questions

Q1. What is Hydrochlorothiazide 25 mg used for?
Hydrochlorothiazide 25 mg is used primarily to treat hypertension and oedema caused by heart failure, liver cirrhosis, or kidney disease. It is a thiazide diuretic that works by increasing urine output to reduce excess fluid and lower blood pressure.

Q2. How long does it take for Hydrochlorothiazide to lower blood pressure?
It begins lowering BP within 3–4 days of initiation. Maximum antihypertensive effect is typically achieved at 3–4 weeks of regular dosing.

Q3. Can Hydrochlorothiazide be taken with Telmisartan or Losartan?
Yes. HCTZ is commonly prescribed in FDC with ARBs such as Telmisartan (40/80 mg) and Losartan (50/100 mg). These combinations provide additive BP-lowering effects. Steris Healthcare manufactures HCTZ-based FDC antihypertensive tablets for the Indian market.

Q4. What are the most common side effects of Hydrochlorothiazide 25 mg?
The most common side effects are hypokalemia (low potassium), dizziness on standing, increased urination, and elevated uric acid (which may trigger gout). Severe hyponatremia is rare but requires immediate attention.

Q5. Who should not take Hydrochlorothiazide?
It is contraindicated in patients with anuria, severe kidney failure, sulfonamide allergy, and uncorrected severe hypokalemia or hyponatremia. Use with caution in diabetics, elderly patients, and those with gout history.

Q6. Is Hydrochlorothiazide safe during pregnancy?
It is Pregnancy Category B and may be used cautiously in the first and second trimester. It should be avoided in the third trimester due to risk of neonatal jaundice and thrombocytopenia. Always consult an obstetrician.

Q7. What foods should I avoid while taking Hydrochlorothiazide?
Avoid excessive alcohol (increases hypotensive risk) and limit sodium-rich foods. Increase potassium-rich foods (bananas, oranges, potatoes, spinach) or take supplements if prescribed. Limit prolonged sun exposure due to photosensitivity risk.

Q8. What is the difference between Hydrochlorothiazide and Furosemide?
Furosemide is a high-ceiling loop diuretic used for acute or severe fluid overload. HCTZ is a low-ceiling thiazide diuretic preferred for chronic hypertension and mild oedema — gentler and suited for once-daily long-term use.

Q10. What is the Schedule classification of Hydrochlorothiazide in India?
It is classified under Schedule H of the Drugs and Cosmetics Act, 1940. It is a prescription-only medicine regulated by CDSCO and can only be dispensed against a valid prescription from a registered medical practitioner.

For Further More Information:

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +918824175417, +919982524671

Buy Now

SHARE WITH